In-vivo dose measurements with MOSFET dosimeters during MV portal imaging

Abstract

background:The purpose of this study was to investigate the feasibility of MOsFeT dosimeter in measuring eye dose during 2D MV portal imaging for setup verification in radiotherapy. Materials and methods:The in-vivo dose measurements were performed by placing the dosimeters over the eyes of 30 brain patients during the acquisition of portal images in linear accelerator by delivering 1 MU with the field sizes of 10 × 10 cm 2 and 15 × 15 cm 2 . results: The mean doses received by the left and right eyes of 10 out of 30 patients when both eyes were completely inside the anterior portal field were found to be 2.56 ± 0.2 cGy and 2.75 ± 0.2, respectively. similarly, for next 10 patients out of the same 30 patients the mean doses to left and right eyes when both eyes were completely out of the anterior portal fields were found to be 0.13 ± 0.02 cGy and 0.17 ± 0.02 cGy, respectively. The mean doses to ipsilateral and contralateral eye for the last 10 patients when one eye was inside the anterior portal field were found to be 3.28 ± 0.2 cGy and 0.36 ± 0.1 cGy, respectively. conclusion:The promising results obtained during 2D MV portal imaging using MOsFeT have shown that this dosimeter is well suitable for assessing low doses during imaging thereby enabling to optimize the imaging procedure using the dosimetric data obtained. In addition, the documentation of the dose received by the patient during imaging procedure is possible with the help of an in-built software in conjunction with the MOsFeT reader module.

Comparison of pre-treatment and in-vivo dosimetry for advanced radiotherapy of prostate cancer

“…There is a wide interest in developing accurate dosimetry tools, such as diverse detectors capable of reconstructing dose distribution in dynamic treatment plans [ 16 – 18 ]. For example, Delta4 phantom applies a 3D phantom with an array of diode detectors on two orthogonal planes.…”